Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation

Mesenchymal stem cells (MSCs) have been shown to improve the outcome of acute renal injury models; but whether MSCs can delay renal failure in chronic kidney disease (CKD) remains unclear. In the present study, the were cultured in media containing various concentrations of basic fibroblast growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Jei-Wen, Tsai, Hsin-Lin, Chen, Chang-Wei, Yang, Hui-Wen, Yang, An-Hang, Yang, Ling-Yu, Wang, Paulus S, Ng, Yee-Yung, Lin, Teng-Lung, Lee, Oscar K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393722/
https://www.ncbi.nlm.nih.gov/pubmed/22862802
http://dx.doi.org/10.1111/j.1582-4934.2012.01610.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393722/
https://www.ncbi.nlm.nih.gov/pubmed/22862802
http://dx.doi.org/10.1111/j.1582-4934.2012.01610.x

Ejemplares similares